Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma.
Fiaschetti G, Abela L, Nonoguchi N, Dubuc AM, Remke M, Boro A, Grunder E, Siler U, Ohgaki H, Taylor MD, Baumgartner M, Shalaby T, Grotzer MA.
Fiaschetti G, et al. Among authors: grotzer ma.
Br J Cancer. 2014 Feb 4;110(3):636-47. doi: 10.1038/bjc.2013.764. Epub 2013 Dec 17.
Br J Cancer. 2014.
PMID: 24346283
Free PMC article.